4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine

C98H97Br4N31O4S — CID 157113903

About 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine

4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine (PubChem CID 157113903) has the molecular formula C98H97Br4N31O4S and a molecular weight of 2124.75 g/mol. Its IUPAC name is 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine.

Molecular Properties

• Compound Name: 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine
• PubChem CID: 157113903
• Molecular Formula: C98H97Br4N31O4S
• Molecular Weight: 2124.75 g/mol
• Exact Mass: 2119.48
• IUPAC Name: 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine
• SMILES: CN(C)S(=O)(=O)c1ccc(Nc2nccn3c(Br)cnc23)cc1.CN(C)c1cccc(Nc2nc(Br)cn3c(-c4cccnc4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(-c4cccc(C(N)=O)c4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(Br)cnc23)c1.COc1nc(Br)cn2c(-c3ccc(N(C)C)cc3)cnc12.Cc1cnc2c(Nc3cccc(N(C)C)c3)nccn12
• InChI: InChI=1S/C21H20N6O.C19H17BrN6.C15H15BrN4O.C15H17N5.C14H14BrN5O2S.C14H14BrN5/c1-26(2)17-8-4-7-16(12-17)25-20-21-24-13-18(27(21)10-9-23-20)14-5-3-6-15(11-14)19(22)28;1-25(2)15-7-3-6-14(9-15)23-18-19-22-11-16(13-5-4-8-21-10-13)26(19)12-17(20)24-18;1-19(2)11-6-4-10(5-7-11)12-8-17-14-15(21-3)18-13(16)9-20(12)14;1-11-10-17-15-14(16-7-8-20(11)15)18-12-5-4-6-13(9-12)19(2)3;1-19(2)23(21,22)11-5-3-10(4-6-11)18-13-14-17-9-12(15)20(14)8-7-16-13;1-19(2)11-5-3-4-10(8-11)18-13-14-17-9-12(15)20(14)7-6-16-13/h3-13H,1-2H3,(H2,22,28)(H,23,25);3-12H,1-2H3,(H,23,24);4-9H,1-3H3;4-10H,1-3H3,(H,16,18);3-9H,1-2H3,(H,16,18);3-9H,1-2H3,(H,16,18)
• InChIKey: AHDYCXKIFYLJHP-UHFFFAOYSA-N
• XLogP: 19.54
• TPSA: 360.08 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 33
• Rotatable Bonds: 22
• Heavy Atoms: 138
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2124.75
LogP ≤ 5	19.54
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	33

Frequently Asked Questions

What is the IUPAC name of 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine?

The IUPAC name of 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine (CID 157113903) is 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine.

What is the SMILES notation for 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine?

The canonical SMILES for 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine is CN(C)S(=O)(=O)c1ccc(Nc2nccn3c(Br)cnc23)cc1.CN(C)c1cccc(Nc2nc(Br)cn3c(-c4cccnc4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(-c4cccc(C(N)=O)c4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(Br)cnc23)c1.COc1nc(Br)cn2c(-c3ccc(N(C)C)cc3)cnc12.Cc1cnc2c(Nc3cccc(N(C)C)c3)nccn12.

What is the InChIKey of 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine?

The InChIKey is AHDYCXKIFYLJHP-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20N6O.C19H17BrN6.C15H15BrN4O.C15H17N5.C14H14BrN5O2S.C14H14BrN5/c1-26(2)17-8-4-7-16(12-17)25-20-21-24-13-18(27(21)10-9-23-20)14-5-3-6-15(11-14)19(22)28;1-25(2)15-7-3-6-14(9-15)23-18-19-22-11-16(13-5-4-8-21-10-13)26(19)12-17(20)24-18;1-19(2)11-6-4-10(5-7-11)12-8-17-14-15(21-3)18-13(16)9-20(12)14;1-11-10-17-15-14(16-7-8-20(11)15)18-12-5-4-6-13(9-12)19(2)3;1-19(2)23(21,22)11-5-3-10(4-6-11)18-13-14-17-9-12(15)20(14)8-7-16-13;1-19(2)11-5-3-4-10(8-11)18-13-14-17-9-12(15)20(14)7-6-16-13/h3-13H,1-2H3,(H2,22,28)(H,23,25);3-12H,1-2H3,(H,23,24);4-9H,1-3H3;4-10H,1-3H3,(H,16,18);3-9H,1-2H3,(H,16,18);3-9H,1-2H3,(H,16,18).

What are the key properties of 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine?

4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine has a molecular weight of 2124.75 g/mol, XLogP of 19.54, 22 rotatable bonds, 6 hydrogen bond donors, and 33 hydrogen bond acceptors.

Where does this data come from?

All data for 4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine is sourced from PubChem (CID 157113903), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).